CEACAM5 and hepatocellular carcinoma: At global multivariate survival analysis, of all clinical and serological factors evaluated, ALT, GGT, LDH, carcinoembryonic antigen (CEA) levels, and Barcelona Clinic Liver Cancer (BCLC) stage were significantly associated with HCC overall survival (HR = 1.01, 95% CI = 1.002–1.017, and p = 0.01; HR = 1.003, 95% CI = 1.001–1.004, and p < 0.001; HR = 1.003, 95% CI = 1.002–1.005, and p < 0.001; HR = 1.015, 95% CI = 1.005–1.025, and p = 0.003; and HR = 2.428, 95% CI = 1.458–4.044, and p = 0.001, resp).